ASHLEY JACKSON: Open Payments
NPI 1124265459 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 15 payments from 8 companies in 2025. Trend: 2023 $473 · 2024 $428 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: EPKINLY, JARDIANCE, AVYCAZ, ZERBAXA, Xermelo, IMBRUVICA, ELIQUIS, MONOFERRIC.
Industry payments across MD — which companies pay providers there.
